The impact of substance P signalling on the development of experimental staphylococcal sepsis and arthritis

Scandinavian Journal of Immunology

Volumn 67, Issue 3, 2008, Pages 253-259

  Verdrengh, M ^a,b   Tarkowski, A ^b  

^a Göteborg University ^*  (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANAEROBIC INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL GROWTH; BONE DESTRUCTION; CARTILAGE DEGENERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; INOCULATION; KIDNEY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ARTHRITIS, INFECTIOUS; BACTEREMIA; FEMALE; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PHAGOCYTOSIS; RECEPTORS, NEUROKININ-1; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; SUBSTANCE P;

EID: 38849120682     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02065.x     Document Type: Article

References (38)

1. Milner P, Ralevic V, Hopwood AM et al. Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia 1989 45 : 121 5.
2. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997 159 : 5654 60.
3. Lai JP, Douglas SD, Rappaport E, Wu JM, Ho WZ. Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol 1998 91 : 121 8.
4. Lambrecht BN, Germonpre PR, Everaert EG et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 1999 29 : 3815 25.
5. Costa SK, Yshii LM, Poston RN, Muscara MN, Brain SD. Pivotal role of endogenous tachykinins and the NK1 receptor in mediating leukocyte accumulation, in the absence of oedema formation, in response to TNFalpha in the cutaneous microvasculature. J Neuroimmunol 2006 171 : 99 109.
6. Blum AM, Metwali A, Elliott DE, Weinstock JV. T cell substance P receptor governs antigen-elicited IFN-gamma production. Am J Physiol Gastrointest Liver Physiol 2003 284 : G197 204.
7. Guo CJ, Lai JP, Luo HM, Douglas SD, Ho WZ. Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes. J Neuroimmunol 2002 131 : 160 7.
8. Sterner-Kock A, Braun RK, van der Vliet A et al. Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils. J Leukoc Biol 1999 65 : 834 40.
9. Tominaga K, Honda K, Akahoshi A et al. Substance P causes adhesion of neutrophils to endothelial cells via protein kinase C. Biol Pharm Bull 1999 22 : 1242 5.
10. Feistritzer C, Clausen J, Sturn DH et al. Natural killer cell functions mediated by the neuropeptide substance P. Regul Pept 2003 116 : 119 26.
11. Weinstock JV, Blum A, Metwali A, Elliott D, Arsenescu R. IL-18 and IL-12 signal through the NF-kappa B pathway to induce NK-1R expression on T cells. J Immunol 2003 170 : 5003 7.
12. Goto T, Tanaka T. Tachykinins and tachykinin receptors in bone. Microsc Res Tech 2002 58 : 91 7.
13. Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1993 20 : 714 7.
14. Krause JE, DiMaggio DA, McCarson KE. Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation. Can J Physiol Pharmacol 1995 73 : 854 9.
15. Matayoshi T, Goto T, Fukuhara E, Takano H, Kobayashi S, Takahashi T. Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells. Biochem Biophys Res Commun 2005 327 : 756 64.
16. Sakai K, Matsuno H, Tsuji H, Tohyama M. Substance P receptor (NK1) gene expression in synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1998 27 : 135 41.
17. Keeble J, Blades M, Pitzalis C, Castro da Rocha FA, Brain SD. The role of substance P in microvascular responses in murine joint inflammation. Br J Pharmacol 2005 144 : 1059 66.
18. Kincy-Cain T, Bost KL. Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II. J Immunol 1996 157 : 255 64.
19. Lighvani S, Huang X, Trivedi PP, Swanborg RH, Hazlett LD. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection. Eur J Immunol 2005 35 : 1567 75.
20. Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992 60 : 2976 85.
21. Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997 65 : 2517 21.
22. Verdrengh M, Erlandsson-Harris H, Tarkowski A. Role of selectins in experimental Staphylococcus aureus-induced arthritis. Eur J Immunol 2000 30 : 1606 13.
23. Bremell T, Lange S, Svensson L et al. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990 33 : 1739 44.
24. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993 61 : 3879 85.
25. Helle M, Boeije L, Aarden LA. Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 1988 18 : 1535 40.
26. Carlsten H, Nilsson LA, Tarkowski A. Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol 1986 81 : 322 5.
27. Josefsson E, Carlsten H, Tarkowski A. Neutrophil mediated inflammatory response in murine lupus. Autoimmunity 1993 14 : 251 7.
28. Saban MR, Saban R, Bjorling D, Haak-Frendscho M. Involvement of leukotrienes, TNF-alpha, and the LFA-1/ICAM-1 interaction in substance P-induced granulocyte infiltration. J Leukoc Biol 1997 61 : 445 51.
29. Nakagawa N, Sano H, Iwamoto I. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration. Peptides 1995 16 : 721 5.
30. Bar-Shavit Z, Goldman R, Stabinsky Y et al. Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980 94 : 1445 51.
31. Bar-Shavit Z, Goldman R. Tuftsin and substance P as modulators of phagocyte functions. Adv Exp Med Biol 1982 141 : 549 58.
32. Rogers DP, Wyatt CR, Walz PH, Drouillard JS, Mosier DA. Bovine alveolar macrophage neurokinin-1 and response to substance P. Vet Immunol Immunopathol 2006 112 : 290 5.
33. Peck R. Neuropeptides modulating macrophage function. Ann N Y Acad Sci 1987 496 : 264 70.
34. Kraneveld AD, Buckley TL, van Heuven-Nolsen D, van Schaik Y, Koster AS, Nijkamp FP. Delayed-type hypersensitivity-induced increase in vascular permeability in the mouse small intestine: inhibition by depletion of sensory neuropeptides and NK1 receptor blockade. Br J Pharmacol 1995 114 : 1483 9.
35. Dianzani C, Collino M, Lombardi G, Garbarino G, Fantozzi R. Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br J Pharmacol 2003 139 : 1103 10.
36. Cao T, Pinter E, Al-Rashed S, Gerard N, Hoult JR, Brain SD. Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: an in vivo study using neurokinin-1 receptor knockout mice. J Immunol 2000 164 : 5424 9.
37. Kidd BL, Inglis JJ, Vetsika K et al. Inhibition of inflammation and hyperalgesia in NK-1 receptor knock-out mice. Neuroreport 2003 14 : 2189 92.
38. Delgado AV, McManus AT, Chambers JP. Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 2003 37 : 355 61.